Insulin detemir weighs in against insulin glargine in type 2 diabetes

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1545, 2006-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Deleterious Outcomes after Abrupt Transition from Insulin Glargine to Insulin Detemir in Patients with Type 1 Diabetes Mellitus

By Kabadi Udaya M.  

Clinical Drug Investigation, Vol. 28, Iss. 11, 2008-01 ,pp. : 697-701

Adis International

Access to resources Recommend Favorite

Insulin glargine and its role in glycaemic management of Type 2 diabetes

By Elrishi MA   Jarvis J   Khunti K   Davies MJ  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 8, 2008-08 ,pp. : 1099-1110

Informa Healthcare

Access to resources Recommend Favorite

Insulin glargine improves glycaemic control in type 1 and 2 diabetes

By  

Inpharma, Vol. 1, Iss. 1458, 2004-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Insulin detemir/insulin glargine: Allergy: case report

By  

Reactions Weekly, Vol. 1, Iss. 1240, 2009-01 ,pp. : 26-26

Adis International

Access to resources Recommend Favorite

Insulin detemir is an effective long-acting human insulin analogue for the treatment of type 1 and 2 diabetes mellitus

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 9, 2005-09 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite